TB-500 UK: The Complete Tissue Repair Peptide Guide

TB-500 (Thymosin Beta-4) is a naturally occurring peptide found throughout the human body, renowned in the research community for its role in cell migration, wound healing, and tissue repair. As interest in peptide therapeutics grows across UK clinics and sports medicine facilities, TB-500 has become one of the most sought-after research compounds available.

What Is TB-500?

TB-500 is the synthetic form of Thymosin Beta-4, a 43-amino acid protein encoded by the TMSB4X gene. It is one of the most abundant peptides in human tissue, particularly platelets and wound fluid, where it plays a central role in the coordinated healing response. The TB-500 designation refers specifically to the active region (amino acids 17–23) of the full Thymosin Beta-4 molecule — the fragment responsible for most of the peptide's biological activity.

Mechanisms of Action

TB-500's healing effects stem from several interconnected mechanisms. Most prominently, the peptide binds to G-actin and sequesters it, preventing actin polymerisation in a way that paradoxically promotes cell motility — essential for the migration of repair cells to injury sites. Additionally, TB-500 upregulates several metalloproteinases (MMPs) that help remodel the extracellular matrix during repair, and promotes the expression of VEGF, accelerating angiogenesis at wound sites.

Research has also demonstrated anti-inflammatory properties through inhibition of inflammatory cytokines including TNF-alpha and IL-6, which may reduce secondary tissue damage during the acute phase of injury.

Research Applications

Published preclinical literature has explored TB-500 across a range of tissue types:

• Cardiac muscle repair following ischaemic injury (multiple rodent studies showing cardiomyocyte regeneration)
• Musculoskeletal healing — tendon, ligament, and muscle injury models
• Corneal repair and wound healing models
• Neurological recovery — peripheral nerve regeneration studies
• Skin wound closure acceleration

Dosing in Research Protocols

Research protocols typically explore doses of 2–5mg administered 2–3 times per week via subcutaneous or intramuscular injection. Loading phases of higher frequency (2–3x weekly for 4–6 weeks) followed by maintenance phases (1–2x weekly) are common in published animal studies. Human clinical research remains limited, though several trials are underway in cardiac applications.

TB-500 Legal Status UK

TB-500 is not classified as a controlled substance under UK law. It is not licensed as a medicine and may only be legally supplied and used for legitimate research purposes. UK clinics and research institutions should ensure appropriate governance frameworks are in place before use.

Where to Buy TB-500 UK

Alluvi supplies pharmaceutical-grade TB-500 (Thymosin Beta-4) directly from GMP-certified Chinese manufacturers, with independent HPLC testing confirming ≥98% purity. Batch CoAs are available on request. Order TB-500 UK with free shipping and a minimum order of £100.